Angiotensin converting enzyme inhibitors and progressive renal insufficiency. Current experience and future directions.
about
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney diseaseDiabetic nephropathy. Prevention and early referral.ANG II promotes autophagy in podocytesAngiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells.First-line pharmacological treatment of hypertension.Treatment of primary chronic glomerulonephritis with immunosuppressive and anti-inflammatory agents. Review.Alpha 1 blockers. Safe, effective treatment for hypertension.Potential side effects of renin inhibitors--mechanisms based on comparison with other renin-angiotensin blockers.Risk for renal injury in diabetic hypertensive patients. Pharmacologic approaches.Tissue and plasma angiotensin converting enzyme and the response to ACE inhibitor drugs.Interventions in chronic renal failureTherapeutic progress. III: Diabetic nephropathy.Renal effects of antihypertensive medications: an overview.Glomerular sclerosis: from rat to man.Effect of chronic treatment with losartan on streptozotocin induced diabetic nephropathy.Angiotensin II induces apoptosis in rat glomerular epithelial cells.Cost-effectiveness of angiotensin-converting enzyme inhibitors in nondiabetic advanced renal disease.Angiotensin-converting enzyme inhibitor use in older patients with heart failure and renal dysfunction.
P2860
Q24235834-26295E4F-2258-4488-B6E7-75EAEAE0CFE2Q33883966-9066AFFB-23E7-4A6D-A7F1-8A16A9F7B06AQ34085732-9DAC5BE8-4898-49A8-8AD2-7975DFC5D1AFQ34150690-F14433AA-471B-460C-8E11-45BCD3488DF0Q35553028-3744ED11-7648-4A7B-895C-60AC4E4FA9F4Q36302682-D058A11F-3C2C-4E62-868A-9AAAAC63662BQ36495545-F38114D2-74C5-4093-AEED-C0EAFFCAA51DQ36565036-7542EC40-DD9C-47EC-B543-8E641151BBC9Q36783078-F21DA9F4-D3E7-4A19-A369-152D50EF02C5Q37170615-DF8ED7DE-9D59-4159-9026-6F52B93C498EQ37975499-E68827B8-A76D-4EA1-9B1A-EEEF412A15E4Q40560448-DFAD37ED-7EDB-49E0-BEF9-6B0AFE3DFCFCQ40711135-3EF85C7E-1141-43E5-8016-88A71390A07BQ40919497-FED65FFB-B1DF-4A0A-826C-3A6BE07B5F51Q43800729-B104CAD2-4397-41E3-A424-9757DA06A2A7Q44024826-261CA499-ABE1-4556-AED8-FCA53047E589Q53155611-F78833C6-4BF5-4484-99C6-1D800DB4ACB7Q53556372-6BA7AF69-7EE8-42DA-839B-8B615AA3C8B7
P2860
Angiotensin converting enzyme inhibitors and progressive renal insufficiency. Current experience and future directions.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh
1989年學術文章
@zh-hant
name
Angiotensin converting enzyme ...... erience and future directions.
@en
type
label
Angiotensin converting enzyme ...... erience and future directions.
@en
prefLabel
Angiotensin converting enzyme ...... erience and future directions.
@en
P2093
P1476
Angiotensin converting enzyme ...... erience and future directions.
@en
P2093
P304
P356
10.7326/0003-4819-111-6-503
P407
P577
1989-09-01T00:00:00Z